NCT00045513View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2002

Primary Completion Date

December 31, 2003

Conditions
LeukemiaLymphoma
Interventions
DRUG

7-hydroxystaurosporine

DRUG

fludarabine phosphate

Trial Locations (3)

L8N 3Z5

McMaster Children's Hospital at Hamilton Health Sciences, Hamilton

N6A 465

London Health Sciences Centre, London

M5G 2M9

Princess Margaret Hospital at University Health Network, Toronto

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University Health Network, Toronto

OTHER

NCT00045513 - Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma | Biotech Hunter | Biotech Hunter